Sinovac Q2 results

Sinovac Biotech Ltd. (SVA -0.5%) Q2 results: Revenues: $12.1M (-30.9%); Operating Expenses: $12.0M (+5.1%); Operating Loss: ($3.0M) (-257.9%); Net Loss: ($2.6M) (-211.9%); Loss Per Share: ($0.04) (-300.0%); Quick Assets: $89.6M (-16.4%); Cash Burn: ($5.6M) (-70.3%).

No financial guidance given.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs